Pyrazolo[1,5-a]pyrimidine acetamides: 4-Phenyl alkyl ether derivatives as potent ligands for the 18 kDa translocator protein (TSPO).

Herein, we report the synthesis of four new phenyl alkyl ether derivatives (7, 9-11) of the pyrazolo[1,5-a]pyrimidine acetamide class, all of which showed high binding affinity and selectivity for the TSPO and, in the case of the propyl, propargyl, and butyl ether derivatives, the ability to increase pregnenolone biosynthesis by 80-175% over baseline in rat C6 glioma cells. While these compounds fit our in silico generated pharmacophore for TSPO binding the current model does not account for the observed functional activity.

[1]  Annelaure Damont,et al.  Evaluation of the PBR/TSPO Radioligand [18F]DPA-714 in a Rat Model of Focal Cerebral Ischemia , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[2]  S. Snyder,et al.  Isolation of the mitochondrial benzodiazepine receptor: association with the voltage-dependent anion channel and the adenine nucleotide carrier. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[3]  Michael Kassiou,et al.  Radiolabelled molecules for imaging the translocator protein (18 kDa) using positron emission tomography. , 2009, Current medicinal chemistry.

[4]  F. Zavala Benzodiazepines, anxiety and immunity. , 1997, Pharmacology & therapeutics.

[5]  F. Holsboer,et al.  Translocator Protein (18 kD) as Target for Anxiolytics Without Benzodiazepine-Like Side Effects , 2009, Science.

[6]  Annelaure Damont,et al.  Comparative Evaluation of the Translocator Protein Radioligands 11C-DPA-713, 18F-DPA-714, and 11C-PK11195 in a Rat Model of Acute Neuroinflammation , 2009, Journal of Nuclear Medicine.

[7]  C. Martini,et al.  2-Arylpyrazolo[1,5-a]pyrimidin-3-yl acetamides. New potent and selective peripheral benzodiazepine receptor ligands. , 2001, Bioorganic & medicinal chemistry.

[8]  M. James,et al.  Development of ligands for the peripheral benzodiazepine receptor. , 2006, Current medicinal chemistry.

[9]  B. Tavitian,et al.  Radiosynthesis of [18F]PBR111, a selective radioligand for imaging the translocator protein (18 kDa) with PET , 2008 .

[10]  S. Meikle,et al.  Synthesis and in vivo evaluation of a novel peripheral benzodiazepine receptor PET radioligand. , 2005, Bioorganic & medicinal chemistry.

[11]  M. Grégoire,et al.  Improved synthesis of the peripheral benzodiazepine receptor ligand [11C]DPA-713 using [11C]methyl triflate. , 2006, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[12]  S. Taliani,et al.  A Virtual Screening Study of the 18 kDa Translocator Protein using Pharmacophore Models Combined with 3D‐QSAR Studies , 2009, ChemMedChem.

[13]  M. James,et al.  [11C]-DPA-713 and [18F]-DPA-714 as New PET Tracers for TSPO: A Comparison with [11C]-(R)-PK11195 in a Rat Model of Herpes Encephalitis , 2009, Molecular Imaging and Biology.

[14]  R. Anholt,et al.  The peripheral-type benzodiazepine receptor. Localization to the mitochondrial outer membrane. , 1986, The Journal of biological chemistry.

[15]  Philippe Hantraye,et al.  11C-DPA-713: A Novel Peripheral Benzodiazepine Receptor PET Ligand for In Vivo Imaging of Neuroinflammation , 2007, Journal of Nuclear Medicine.

[16]  K. Furukawa,et al.  Involvement of neurosteroids in the anxiolytic-like effects of AC-5216 in mice , 2008, Pharmacology Biochemistry and Behavior.

[17]  M. Pomper,et al.  Initial Evaluation of 11C-DPA-713, a Novel TSPO PET Ligand, in Humans , 2009, Journal of Nuclear Medicine.

[18]  S. Snyder,et al.  Peripheral type benzodiazepine receptors. , 1989, Annual review of pharmacology and toxicology.

[19]  M. Kassiou,et al.  The translocator protein (18 kDa): central nervous system disease and drug design. , 2009, Journal of medicinal chemistry.

[20]  F. Da Settimo,et al.  Translocator protein ligands as promising therapeutic tools for anxiety disorders. , 2009, Current medicinal chemistry.

[21]  Abraham Weizman,et al.  Enigma of the peripheral benzodiazepine receptor. , 1999, Pharmacological reviews.

[22]  V. Papadopoulos,et al.  Peripheral benzodiazepine receptor in cholesterol transport and steroidogenesis , 1997, Steroids.

[23]  A. Guidotti,et al.  The pharmacology of neurosteroidogenesis , 1994, The Journal of Steroid Biochemistry and Molecular Biology.

[24]  B. Dutrillaux,et al.  The Peripheral Benzodiazepine Receptors: A Review , 2004, Journal of Neuro-Oncology.

[25]  Denis Guilloteau,et al.  DPA-714, a New Translocator Protein–Specific Ligand: Synthesis, Radiofluorination, and Pharmacologic Characterization , 2008, Journal of Nuclear Medicine.

[26]  H. Alho,et al.  Expression of mitochondrial benzodiazepine receptor and its putative endogenous ligand diazepam binding inhibitor in cultured primary astrocytes and C-6 cells: relation to cell growth. , 1994, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[27]  V. Papadopoulos,et al.  Mitochondrial benzodiazepine receptors and the regulation of steroid biosynthesis. , 1992, Annual review of pharmacology and toxicology.

[28]  D. Nutt,et al.  Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. , 2006, Trends in pharmacological sciences.

[29]  C. Martini,et al.  Peripheral benzodiazepine receptor ligands: mitochondrial transmembrane potential depolarization and apoptosis induction in rat C6 glioma cells. , 2004, Biochemical pharmacology.

[30]  M. Gavish,et al.  Biochemical, Physiological, and Pathological Aspects of the Peripheral Benzodiazepine Receptor , 1992, Journal of neurochemistry.